HRAS and hepatocellular carcinoma: Liu demonstrated in hepatocellular carcinoma cell lines that nEGFR can affect cell apoptosis by stimulating the expression of SOS1, which then activates the HRAS/PI3K/AKT pathway, leading to nuclear translocation of p-AKT and Bcl-2.